These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4112005)

  • 1. [The action and place of 2 alpha-methyl dihydrotestosterone in the treatment of breast cancer].
    Spithakis R
    Mars Med; 1972; 109(2):171-3. PubMed ID: 4112005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of fibrocystic mastopathy with 2-alpha-methyl-dihydrotestosterone propionate].
    Jacobelli G; Ruggeri F
    Cancro; 1967; 20(5):557-66. PubMed ID: 5632753
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of mastisol (2-alpha-methylandrostan-17-beta-ol-3-one propionate) and testosterone propionate in the treatment of advanced and recurrent cancer of the breast.
    Amaaki T; Enomoto K; Shimada S; Nagai K; Minagawa N
    Nihon Geka Hokan; 1969 Jul; 38(4):652-7. PubMed ID: 5394603
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined hormone therapy in advanced breast cancer. Triple-blind study of 68 patients treated with dromostanolone and fluorometholone.
    Gaertner RA; Lewison EF; Finney GG; Montague AC
    Johns Hopkins Med J; 1968 Sep; 123(3):138-41. PubMed ID: 4876823
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of disseminated mammary carcinoma with drostanolone propionate.
    Brown IG
    Practitioner; 1970 Sep; 205(227):336-7. PubMed ID: 5536680
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term survival after treatment of breast cancer thoracic metastases through the association, right from the beginning, of hormonotherapy and non hormonal antineoplastic chemotherapy (author's transl)].
    Mannes P; Derriks R; Moens R
    Acta Tuberc Pneumol Belg; 1971; 62(5):473-77. PubMed ID: 5172849
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effects of CS 1507 in mammary gland cancer].
    Pinel P
    Therapeutique; 1969 Dec; 45(10):1009-11. PubMed ID: 5396159
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term combined administration of dromostanolone propionate (Mastisol) and cyclophosphamide (Endoxan) for advanced breast cancer after surgical hormone therapy].
    Nomura Y; Hattori T; Abe Y; Iguchi K
    Gan No Rinsho; 1971 Dec; 17(12):899-904. PubMed ID: 5172404
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormonal therapy of advanced breast cancer with drostanolone propionate].
    Petit JC; Klein T; Rodier D
    Bull Cancer; 1971; 58(4):511-22. PubMed ID: 4115657
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of metastasising mammary carcinoma with drostanolone propionate (masterid) (author's transl)].
    von Lieven H; Büll U
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2043-6. PubMed ID: 4216810
    [No Abstract]   [Full Text] [Related]  

  • 11. Palliative care in the elderly breast cancer patient.
    Laird BJ; Fallon MT
    Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):131-9. PubMed ID: 19070470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of drostanolone propionate (Masteril) and nandrolone decanoate (Deca-durabolin) in the treatment of breast carcinoma.
    Chowdhury MS; Banks AJ; Bond WH; Jones WG; Ward HW
    Clin Oncol; 1976 Sep; 2(3):203-6. PubMed ID: 1036981
    [No Abstract]   [Full Text] [Related]  

  • 13. [A complement to the palliative treatment of disseminated breast cancer].
    Reboul J; Azaloux H; Vilayleck S; Moretti JL; Ducourneau P; Buy B
    Bord Med; 1972 Feb; 5(4):355-8. PubMed ID: 4114669
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of breast cancer in aged women].
    Berta V; Perelli-Ercolini M; Beani G
    Chir Ital; 1980 Dec; 32(6):1543-51. PubMed ID: 6894717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative treatment of metastasized breast cancer with 5-FU in slow intravenous infusion.
    Huys J; Van Vaerenbergh PM
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):775-80. PubMed ID: 4189483
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone treatment of patients with breast carcinoma].
    Sauter C
    Praxis (Bern 1994); 1995 Jun; 84(24):713-7. PubMed ID: 7540769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of dromostanolone propionate for mastopathy--with special reference to screening of breast cancer].
    Takeuchi S; Yoshida M
    Saishin Igaku; 1967 May; 22(5):1049-54. PubMed ID: 5630583
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of breast cancer.
    Bateman JC
    J Am Med Womens Assoc; 1965 Oct; 20(10):946-50. PubMed ID: 4157697
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with dromostanolone propionate (NSC-12198) in breast carcinoma.
    Seay DG; Bradshaw JD; Nicol NT
    Cancer Chemother Rep; 1972 Feb; 56(1):89-92. PubMed ID: 5067664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.